Latest News in Pharma industry4 hours agoUCB Shifts Focus After Parkinson’s Drug Trial Failure: A New Hope with Glovadalen12 hours agoMerck Strikes $2 Billion Deal with Hansoh for Game-Changing Oral Obesity Drug2 days agoGSK’s Jemperli Receives EMA’s Green Light for Expanded Approval in Endometrial Cancer, Paving the Way for Life-Saving Treatment2 days agoPureTech's Breakthrough Drug Deupirfenidone Sets New Benchmark in IPF Treatment with Groundbreaking Phase IIb Results4 days agoNovo Nordisk’s $16.5 Billion Deal to Supercharge Weight-Loss Drug Production Amid Global Demand Surge5 days agoUK's Landmark Clinical Trials Overhaul Poised to Revolutionize Healthcare and Drive Pharma Innovation7 days agoCandel Therapeutics’ CAN-2409 Achieves Breakthrough in Prostate Cancer Treatment with Groundbreaking Phase III Results8 days agoNew Amsterdam Pharma’s Obicetrapib Triumphs in Phase III BROADWAY Trial, Stock Soars 35%9 days agoLantern Pharma's LP-300 Shines in Phase II Lung Cancer Trial: Breakthrough for Never-Smokers in Asia10 days agoDefense Bill Showdown: Biosecure Act Dropped Amid Controversy, Gender-Affirming Care Restrictions Spark Debate13 days agoEli Lilly's $3 Billion Wisconsin Expansion to Boost Production of In-Demand Weight-Loss and Diabetes Drugs, Creating 750 Jobs13 days agoFDA Fast-Tracks Merus' Bizengri for Rare Pancreatic and Lung Cancers: A New Era in Targeted Therapy14 days agoEli Lilly's Zepbound Redefines Obesity Treatment with 52% Greater Weight Loss Than Wegovy, Setting a New Industry Benchmark14 days agoRefoxy Pharmaceuticals Raises €9.1 Million to Pioneer FOXO3 Therapies for Aging Diseases16 days agoOral GLP-1 Receptor Agonists Set to Revolutionize Obesity Treatment: Novo Nordisk, Eli Lilly, and New Players Lead the Charge19 days agoRevolutionary 'Pill-on-a-Thread' Cancer Screening Trial Aims to Save Thousands in the UK20 days agoFasenra's Phase II ABRA Study Reveals Game-Changing Results for Eosinophilic Asthma Treatment22 days agoBiden's Plan to Expand Medicare and Medicaid for Weight-Loss Drugs Could Transform Obesity Treatment, But Faces Political Hurdles23 days agoMajor Blow for Cassava Sciences as Alzheimer's Drug Fails Phase III Trial, Stock Plummets 85%24 days agoFDA Greenlights BridgeBio's Attruby, Challenging Pfizer's Dominance in Deadly Heart Disease Market25 days agoBridgeBio Pharma's Attruby Approved by FDA: A Game-Changer in the Fight Against ATTR-CM, Taking on Pfizer's $3.3B Market Stronghold26 days agoHumacyte's ATEV: A Game-Changer in Trauma Care with Breakthrough Clinical Results27 days agoNewAmsterdam Pharma's Cholesterol-Lowering Drug Shows Promising Results, But Investor Caution Remains28 days agoRevolutionizing ALS Treatment: WideTrial and NIH Launch $22M Ibudilast Access Program28 days agoJohnson & Johnson Faces Landmark UK Lawsuit Over Alleged Cancer Risks Linked to Talcum Powder29 days agoBrookfield's $6.9 Billion Bid for Grifols Sparks Shareholder Showdown Amid Pharma Industry Shake-Up30 days agoRevolutionary AHA 2024 Findings: GLP-1 Agonists Show Life-Saving Potential Beyond Diabetes34 days agoRevolutionizing Drug Testing: Intelligent Bio Solutions Unveils Groundbreaking Fingerprint Sweat Analysis34 days agoEMA Reverses Stance: Limited Approval of Alzheimer's Drug Leqembi Brings Hope and Caution to Europe35 days agoSyros Pharmaceuticals Crashes: Major Trial Failure Sparks 76% Stock Plunge and Loan Default35 days agoBioNTech's $1 Billion Gamble: Bold Acquisition of Chinese Biotech Firm to Revolutionize Cancer Treatment35 days agoDongyangguang Pharma Strikes Landmark Global Deal with Apollo to Revolutionize Diabetes and Obesity Treatment36 days agoJohnson & Johnson to Cut Thousands of Jobs in China Amid Major Market Overhaul37 days agoNuzyra Shows Promising Results in Tough-to-Treat NTM Lung Disease37 days agoAbbVie’s $40 Billion Setback: Emraclidine Trial Failure Shakes Pharma Market and Exposes Neuroscience Challenges40 days agoTezspire Shakes Up Biopharma Market with Breakthrough CRSwNP Trial Results, Poised to Challenge Dupixent's Reign40 days agoTezspire Shakes Up Biopharma Market with Breakthrough CRSwNP Trial Results, Poised to Challenge Dupixent's Reign41 days agoGroundbreaking Mpox Vaccine Trial Targets Pregnant Women and Infants: A Game-Changer for Global Health?42 days agoTrump's Healthcare Overhaul: What Changes, Challenges, and Opportunities Lie Ahead?44 days agoTEV-479: A Game-Changer in Schizophrenia Treatment with Breakthrough Phase III Results47 days agoApotex Eyes Landmark 2024 IPO: Paving the Way for Affordable Healthcare and Industry Innovation47 days agoSunbird Bio's 86% Accurate Blood Test for Parkinson's: A Major Leap in Non-Invasive Diagnostics49 days agoAstraZeneca China President Lei Wang Under Investigation Amid Major Healthcare Fraud Allegations49 days agoBreakthrough Phase II Trial Launches Hope for Glioblastoma Patients: Ropidoxuridine Aims to Redefine Survival50 days agoTremfya and Omvoh Set to Revolutionize Crohn’s Disease Treatment with Impressive Trial Results50 days agoModerna and MSD Launch Groundbreaking Trial for Personalized Lung Cancer Treatment with mRNA Therapy50 days agoPfizer Boosts 2024 Forecast Amid Rising Pressure from Activist Investor Over $20B 'Lost Value'54 days agoAbbott's TEAM-HF Trial Explores Early HeartMate 3 Use to Revolutionize Heart Failure Treatment56 days agoGenelux Kicks Off Phase II VIRO-25 Trial: A New Hope for Recurrent NSCLC with Innovative Olvi-Vec Therapy56 days agoEli Lilly's Alzheimer's Drug Faces NICE Rejection Over Cost Concerns, Final Decision LoomsLoad More
